Showing results (411-420 of 472) with videos related to

Sort By:
Pageof 48
British Journal of Haematology|July 23, 2016
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphomaSteven I Park, Natalie S Grover, Oludamilola Olajide, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2017
Associations of Vitamin D-Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA)Cassianne Robinson-Cohen, Leila R Zelnick, Andrew N Hoofnagle, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffoldPiotr P Graczyk, Afzal Khan, Gurpreet S Bhatia, et al.
Pain|April 10, 2009
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)Robert H Dworkin, Dennis C Turk, Dennis A Revicki, et al.
Life Sciences|June 13, 2001
Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brainJ S Fowler, N D Volkow, J Logan, et al.
Pediatrics|January 6, 2026
Improving Pediatric Concussion Management in the Primary Care SettingCorinna J Rea, Rachel Sklar, Eli Sprecher, et al.
Diabetes, Obesity & Metabolism|October 25, 2019
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Hepatology Communications|February 10, 2025
Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver diseaseErin S Coyne, Yilin Nie, Darwin Lee, et al.
Bone Marrow Transplantation|November 21, 2012
Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCTW A Wood, J Whitley, R Goyal, et al.
Investigational New Drugs|December 20, 2014
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemiasR Tibes, K T McDonagh, L Lekakis, et al.
Pageof 48